| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.572 | 0.009 | 0.572 | Calcium channel L-type activator | 0.253 0.202 CID_54460935 | ||
| 0.54 | 0.007 | 0.54 | Peroxidase inhibitor | 0.365 0.026 CID_54460935 | ||
| 0.518 | 0.021 | 0.518 | GABA C receptor rho-3 antagonist | 0.277 0.133 CID_54460935 | ||
| 0.495 | 0.005 | 0.495 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 CID_54460935 | ||
| 0.51 | 0.031 | 0.51 | Aldehyde oxidase inhibitor | |||
| 0.485 | 0.01 | 0.485 | Interleukin 2 agonist | 0.197 0.194 CID_54460935 | ||
| 0.498 | 0.028 | 0.498 | 5 Hydroxytryptamine release stimulant | |||
| 0.477 | 0.036 | 0.477 | Cholesterol antagonist | 0.385 0.053 CID_54460935 | ||
| 0.425 | 0.015 | 0.425 | Interleukin agonist | |||
| 0.419 | 0.024 | 0.72 | Superoxide dismutase inhibitor | 0.72 0.004 CID_54460935 | CID_54460935 | |
| 0.469 | 0.073 | 0.469 | Caspase 9 stimulant | |||
| 0.365 | 0.005 | 0.365 | Carbonic anhydrase XV inhibitor | 0.191 0.02 CID_54460935 | ||
| 0.361 | 0.004 | 0.361 | Porphobilinogen synthase inhibitor | 0.101 0.035 CID_54460935 | ||
| 0.421 | 0.065 | 0.504 | Histamine release inhibitor | 0.504 0.027 CID_54460935 | CID_54460935 | |
| 0.36 | 0.005 | 0.36 | Histidine decarboxylase inhibitor | |||
| 0.374 | 0.021 | 0.399 | RNA-directed DNA polymerase inhibitor | 0.399 0.018 CID_54460935 | CID_54460935 | |
| 0.372 | 0.022 | 0.372 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.355 | 0.007 | 0.355 | GABA C receptor agonist | 0.1 0.066 CID_54460935 | ||
| 0.356 | 0.011 | 0.356 | Protein kinase stimulant | |||
| 0.372 | 0.037 | 0.372 | Calcium channel activator | 0.238 0.161 CID_54460935 | ||
| 0.363 | 0.028 | 0.363 | DNA synthesis inhibitor | 0.202 0.12 CID_54460935 | ||
| 0.37 | 0.035 | 0.37 | DNA damaging | |||
| 0.356 | 0.024 | 0.356 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.405 | 0.075 | 0.405 | 5 Hydroxytryptamine release inhibitor | |||
| 0.354 | 0.023 | 0.354 | Anesthetic general | |||
| 0.335 | 0.011 | 0.335 | Neurotrophic factor enhancer | |||
| 0.412 | 0.09 | 0.412 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.352 | 0.032 | 0.842 | Angiogenesis stimulant | 0.842 0.003 CID_54460935 | CID_54460935 | |
| 0.321 | 0.008 | 0.321 | Nitric-oxide synthase stimulant | |||
| 0.326 | 0.017 | 0.326 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.323 | 0.015 | 0.323 | Amylase inhibitor | |||
| 0.315 | 0.017 | 0.462 | Phospholipase C inhibitor | 0.462 0.007 CID_54460935 | CID_54460935 | |
| 0.305 | 0.01 | 0.305 | UDP-glucose 4-epimerase inhibitor | |||
| 0.296 | 0.006 | 0.296 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.315 | 0.026 | 0.315 | Tyrosine 3 hydroxylase inhibitor | 0.182 0.172 CID_54460935 | ||
| 0.292 | 0.007 | 0.292 | NADH dehydrogenase inhibitor | 0.146 0.019 CID_54460935 | ||
| 0.333 | 0.052 | 0.333 | Aryl hydrocarbon receptor agonist | |||
| 0.285 | 0.004 | 0.285 | HIV-1 integrase (Overall Integration) inhibitor | 0.172 0.018 CID_54460935 | ||
| 0.274 | 0.005 | 0.4 | Triose-phosphate isomerase inhibitor | 0.4 0.003 CID_54460935 | CID_54460935 | |
| 0.276 | 0.01 | 0.276 | Ferrochelatase inhibitor | |||
| 0.336 | 0.08 | 0.336 | Vasodilator, peripheral | |||
| 0.27 | 0.017 | 0.27 | MAP kinase kinase 3 inhibitor | 0.208 0.1 CID_54460935 | ||
| 0.25 | 0.01 | 0.25 | Adenylate kinase inhibitor | 0.157 0.024 CID_54460935 | ||
| 0.312 | 0.075 | 0.397 | Immunostimulant | 0.397 0.05 CID_54460935 | CID_54460935 | |
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | |||
| 0.247 | 0.013 | 0.247 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.243 | 0.009 | 0.243 | Carbonic anhydrase VI inhibitor | 0.15 0.021 CID_54460935 | ||
| 0.253 | 0.021 | 0.253 | Succinate dehydrogenase inhibitor | 0.18 0.068 CID_54460935 | ||
| 0.316 | 0.087 | 0.316 | Transcription factor NF kappa B inhibitor | |||
| 0.238 | 0.01 | 0.238 | Carbonic anhydrase III inhibitor | 0.166 0.023 CID_54460935 | ||
| 0.236 | 0.02 | 0.236 | Hexokinase inhibitor | |||
| 0.3 | 0.088 | 0.3 | Vasodilator, coronary | |||
| 0.22 | 0.009 | 0.22 | GABA C receptor antagonist | 0.186 0.016 CID_54460935 | ||
| 0.23 | 0.019 | 0.23 | Alkylator | 0.162 0.041 CID_54460935 | ||
| 0.242 | 0.036 | 0.242 | Lipocortins synthesis antagonist | |||
| 0.324 | 0.118 | 0.485 | Antibacterial | 0.485 0.045 CID_54460935 | CID_54460935 | |
| 0.23 | 0.024 | 0.23 | Anesthetic local | |||
| 0.221 | 0.019 | 0.221 | GABA C receptor rho-2 antagonist | |||
| 0.214 | 0.015 | 0.214 | CF transmembrane conductance regulator agonist | |||
| 0.197 | 0.005 | 0.197 | Glutamate release inhibitor | |||
| 0.2 | 0.008 | 0.2 | GABA C receptor rho-1 antagonist | |||
| 0.281 | 0.089 | 0.281 | Caspase 3 stimulant | |||
| 0.215 | 0.024 | 0.215 | Aldehyde dehydrogenase inhibitor | |||
| 0.214 | 0.023 | 0.214 | Adenylate cyclase inhibitor | |||
| 0.286 | 0.095 | 0.286 | Apoptosis antagonist | |||
| 0.195 | 0.006 | 0.195 | Biliverdin reductase inhibitor | 0.052 0.05 CID_54460935 | ||
| 0.2 | 0.011 | 0.2 | Phosphofructokinase-1 inhibitor | 0.097 0.033 CID_54460935 | ||
| 0.201 | 0.014 | 0.212 | Carbonic anhydrase XIII inhibitor | 0.212 0.012 CID_54460935 | CID_54460935 | |
| 0.258 | 0.072 | 0.258 | Hypoglycemic | |||
| 0.197 | 0.013 | 0.197 | Photosensitizer | 0.099 0.09 CID_54460935 | ||
| 0.197 | 0.015 | 0.197 | Adenylate cyclase stimulant | 0.175 0.031 CID_54460935 | ||
| 0.33 | 0.152 | 0.33 | Apoptosis agonist | |||
| 0.237 | 0.06 | 0.237 | MAP kinase kinase 2 inhibitor | |||
| 0.179 | 0.008 | 0.179 | Alcohol oxidase inhibitor | |||
| 0.176 | 0.007 | 0.176 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.257 | 0.09 | 0.257 | Insulysin inhibitor | |||
| 0.182 | 0.018 | 0.182 | Mucolytic | |||
| 0.188 | 0.025 | 0.188 | MAP kinase 9 inhibitor | |||
| 0.169 | 0.01 | 0.169 | Toll-Like receptor 3 antagonist | 0.097 0.056 CID_54460935 | ||
| 0.223 | 0.065 | 0.223 | DNA methylase inhibitor | |||
| 0.217 | 0.061 | 0.217 | DNA methyltransferase I inhibitor | |||
| 0.173 | 0.017 | 0.173 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.181 | 0.025 | 0.181 | Expectorant | |||
| 0.168 | 0.014 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.13 0.118 CID_54460935 | ||
| 0.19 | 0.037 | 0.412 | Hemostatic | 0.412 0.007 CID_54460935 | CID_54460935 | |
| 0.157 | 0.005 | 0.157 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.192 | 0.04 | 0.192 | Arachidonic acid antagonist | 0.131 0.112 CID_54460935 | ||
| 0.174 | 0.022 | 0.174 | MAP kinase 8 inhibitor | |||
| 0.16 | 0.008 | 0.197 | Carbonic anhydrase VB inhibitor | 0.197 0.005 CID_54460935 | CID_54460935 | |
| 0.16 | 0.01 | 0.16 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 CID_54460935 | ||
| 0.179 | 0.03 | 0.179 | Cystathionine beta-synthase inhibitor | |||
| 0.161 | 0.016 | 0.161 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.16 | 0.014 | 0.16 | Glutamate dehydrogenase inhibitor | 0.091 0.036 CID_54460935 | ||
| 0.172 | 0.027 | 0.172 | Interleukin 1b antagonist | |||
| 0.208 | 0.064 | 0.208 | I kappa B kinase epsilon inhibitor | |||
| 0.147 | 0.004 | 0.147 | Secretase gamma inhibitor | |||
| 0.152 | 0.011 | 0.152 | Carbamoyl phosphate synthetase inhibitor | 0.092 0.023 CID_54460935 | ||
| 0.149 | 0.008 | 0.149 | GABA aminotransferase inhibitor | |||
| 0.18 | 0.04 | 0.252 | Cell wall synthesis inhibitor | 0.252 0.015 CID_54460935 | CID_54460935 | |
| 0.152 | 0.014 | 0.186 | Carbonic anhydrase V inhibitor | 0.186 0.008 CID_54460935 | CID_54460935 | |
| 0.149 | 0.012 | 0.149 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.147 | 0.011 | 0.147 | Interferon agonist | 0.099 0.029 CID_54460935 | ||
| 0.2 | 0.063 | 0.2 | LIM domain kinase 1 inhibitor | |||
| 0.156 | 0.021 | 0.156 | Creatine kinase inhibitor | 0.096 0.064 CID_54460935 | ||
| 0.147 | 0.012 | 0.147 | Argininosuccinate synthase inhibitor | |||
| 0.143 | 0.008 | 0.143 | Purinergic P2X1 antagonist | 0.096 0.018 CID_54460935 | ||
| 0.161 | 0.028 | 0.161 | Bronchodilator | |||
| 0.198 | 0.066 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.145 | 0.014 | 0.145 | Interleukin 12 antagonist | |||
| 0.238 | 0.108 | 0.238 | Lipoxygenase inhibitor | 0.178 0.166 CID_54460935 | ||
| 0.162 | 0.033 | 0.221 | Aminopeptidase B inhibitor | 0.221 0.017 CID_54460935 | CID_54460935 | |
| 0.165 | 0.036 | 0.165 | Cathepsin H inhibitor | 0.112 0.087 CID_54460935 | ||
| 0.168 | 0.041 | 0.168 | Toll-Like receptor 2 antagonist | |||
| 0.134 | 0.006 | 0.134 | Potassium channel (ATP-sensitive) blocker | |||
| 0.133 | 0.006 | 0.133 | Topoisomerase II beta inhibitor | |||
| 0.148 | 0.022 | 0.148 | DOPA decarboxylase inhibitor | |||
| 0.136 | 0.01 | 0.136 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.153 | 0.029 | 0.153 | DNA repair enzyme inhibitor | |||
| 0.177 | 0.054 | 0.177 | Neurotensin receptor agonist | |||
| 0.175 | 0.053 | 0.175 | Interferon gamma antagonist | |||
| 0.163 | 0.042 | 0.163 | Monophenol monooxygenase inhibitor | 0.126 0.058 CID_54460935 | ||
| 0.13 | 0.01 | 0.13 | D-Ala-D-Ala ligase inhibitor | |||
| 0.154 | 0.034 | 0.154 | Vanilloid 1 agonist | |||
| 0.163 | 0.043 | 0.163 | MAP3K9 inhibitor | |||
| 0.146 | 0.028 | 0.177 | Gastric antisecretory | 0.177 0.017 CID_54460935 | CID_54460935 | |
| 0.158 | 0.042 | 0.158 | Cyclooxygenase 3 inhibitor | |||
| 0.131 | 0.015 | 0.136 | Carbonic anhydrase VA inhibitor | 0.136 0.014 CID_54460935 | CID_54460935 | |
| 0.246 | 0.13 | 0.42 | Antithrombotic | 0.42 0.044 CID_54460935 | CID_54460935 | |
| 0.316 | 0.2 | 0.607 | Antiinflammatory | 0.607 0.052 CID_54460935 | CID_54460935 | |
| 0.136 | 0.023 | 0.136 | MAP kinase kinase 1 inhibitor | |||
| 0.154 | 0.041 | 0.154 | DNA intercalator | |||
| 0.193 | 0.081 | 0.193 | Insulin sensitizer | |||
| 0.132 | 0.02 | 0.132 | Adrenaline agonist | |||
| 0.157 | 0.047 | 0.157 | MAP kinase kinase inhibitor | |||
| 0.12 | 0.01 | 0.12 | Estrogen-related receptor beta agonist | |||
| 0.212 | 0.106 | 0.212 | Antioxidant | |||
| 0.159 | 0.052 | 0.159 | Interleukin 1 antagonist | |||
| 0.167 | 0.061 | 0.167 | Protein kinase C nu inhibitor | |||
| 0.113 | 0.009 | 0.113 | Interferon inducer | 0.083 0.021 CID_54460935 | ||
| 0.123 | 0.02 | 0.123 | Keratolytic | |||
| 0.132 | 0.031 | 0.132 | Nitric-oxide synthase inhibitor | 0.099 0.061 CID_54460935 | ||
| 0.131 | 0.031 | 0.131 | Prolactin inhibitor | |||
| 0.234 | 0.135 | 0.234 | Prostaglandin dehydrogenase inhibitor | |||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR6) antagonist | |||
| 0.141 | 0.043 | 0.141 | Microtubule formation inhibitor | |||
| 0.128 | 0.031 | 0.128 | Electrolyte absorption antagonist | |||
| 0.209 | 0.112 | 0.209 | Spasmolytic | 0.19 0.128 CID_54460935 | ||
| 0.121 | 0.025 | 0.121 | Transcription factor NF kappa B stimulant | |||
| 0.117 | 0.022 | 0.117 | Glutamate decarboxylase inhibitor | |||
| 0.105 | 0.009 | 0.105 | MAP kinase kinase 7 inhibitor | |||
| 0.184 | 0.09 | 0.184 | Psychostimulant | |||
| 0.222 | 0.127 | 0.222 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.122 | 0.029 | 0.122 | Thioredoxin inhibitor | |||
| 0.147 | 0.054 | 0.147 | Heat shock protein 70 antagonist | |||
| 0.101 | 0.008 | 0.101 | Aconitate hydratase inhibitor | |||
| 0.105 | 0.012 | 0.105 | Phosphorylase inhibitor | 0.062 0.024 CID_54460935 | ||
| 0.132 | 0.041 | 0.132 | Transcription factor STAT6 inhibitor | |||
| 0.1 | 0.008 | 0.1 | Sphingosine kinase 2 inhibitor | |||
| 0.126 | 0.034 | 0.126 | Anabolic | 0.123 0.036 CID_54460935 | ||
| 0.142 | 0.052 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.127 | 0.037 | 0.127 | Toll-Like receptor 4 antagonist | |||
| 0.203 | 0.113 | 0.203 | Neuropeptide Y2 antagonist | |||
| 0.113 | 0.024 | 0.113 | Myeloperoxidase inhibitor | |||
| 0.167 | 0.08 | 0.167 | Tumour necrosis factor antagonist | |||
| 0.189 | 0.102 | 0.189 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.148 | 0.061 | 0.148 | MAO inhibitor | |||
| 0.098 | 0.011 | 0.098 | Carbonic anhydrase XIV inhibitor | |||
| 0.14 | 0.054 | 0.14 | Topoisomerase II inhibitor | |||
| 0.109 | 0.024 | 0.109 | mTOR complex 2 inhibitor | |||
| 0.099 | 0.014 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.08 0.038 CID_54460935 | ||
| 0.125 | 0.041 | 0.135 | Acetylcholine release stimulant | 0.135 0.029 CID_54460935 | CID_54460935 | |
| 0.181 | 0.098 | 0.181 | Anticonvulsant | |||
| 0.102 | 0.019 | 0.173 | NMDA receptor agonist | 0.173 0.006 CID_54460935 | CID_54460935 | |
| 0.148 | 0.064 | 0.154 | Cytokine production inhibitor | 0.154 0.059 CID_54460935 | CID_54460935 | |
| 0.09 | 0.008 | 0.129 | Alpha-mannosidase inhibitor | 0.129 0.004 CID_54460935 | CID_54460935 | |
| 0.189 | 0.107 | 0.189 | Antiamyloidogenic | |||
| 0.092 | 0.01 | 0.092 | MDM2 inhibitor | |||
| 0.087 | 0.005 | 0.087 | Thymidylate synthase inhibitor | |||
| 0.143 | 0.061 | 0.143 | Toll-Like receptor antagonist | |||
| 0.147 | 0.066 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.098 | 0.017 | 0.098 | NMDA receptor glycine site agonist | |||
| 0.18 | 0.099 | 0.18 | Histone acetyltransferase inhibitor | |||
| 0.128 | 0.046 | 0.128 | Protein kinase C gamma inhibitor | |||
| 0.087 | 0.007 | 0.087 | Sodium/calcium exchanger inhibitor | 0.059 0.02 CID_54460935 | ||
| 0.087 | 0.007 | 0.138 | Mannosidase inhibitor | 0.138 0.004 CID_54460935 | CID_54460935 | |
| 0.088 | 0.009 | 0.088 | Lysine-specific demethylase 1A inhibitor | |||
| 0.119 | 0.042 | 0.119 | Sphingomyelinase inhibitor | |||
| 0.116 | 0.04 | 0.116 | DNA directed RNA polymerase inhibitor | |||
| 0.11 | 0.034 | 0.11 | Ornithine decarboxylase inhibitor | |||
| 0.079 | 0.004 | 0.079 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 CID_54460935 | ||
| 0.104 | 0.029 | 0.104 | HIV-1 reverse transcriptase inhibitor | |||
| 0.147 | 0.073 | 0.147 | MAP kinase 3 inhibitor | |||
| 0.107 | 0.034 | 0.107 | I kappa B kinase inhibitor | |||
| 0.084 | 0.011 | 0.084 | Potassium channel (Inward rectifier) blocker | |||
| 0.081 | 0.008 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 CID_54460935 | ||
| 0.081 | 0.009 | 0.081 | Beta 2 adrenoreceptor agonist | |||
| 0.1 | 0.028 | 0.1 | Aminopeptidase I inhibitor | |||
| 0.095 | 0.024 | 0.095 | Glycine receptor agonist | |||
| 0.075 | 0.004 | 0.075 | Glutamate (mGluR8) agonist | |||
| 0.097 | 0.026 | 0.097 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.106 | 0.036 | 0.106 | Topoisomerase II alpha inhibitor | |||
| 0.093 | 0.022 | 0.093 | GABA B receptor agonist | |||
| 0.079 | 0.009 | 0.079 | Adenosine deaminase inhibitor | 0.075 0.011 CID_54460935 | ||
| 0.122 | 0.052 | 0.122 | Chelator | |||
| 0.109 | 0.041 | 0.119 | Protein kinase C zeta inhibitor | 0.119 0.033 CID_54460935 | CID_54460935 | |
| 0.17 | 0.102 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.134 | 0.067 | 0.134 | Cyclooxygenase 1 inhibitor | |||
| 0.082 | 0.015 | 0.082 | Sphingosine kinase inhibitor | 0.06 0.039 CID_54460935 | ||
| 0.086 | 0.02 | 0.086 | Ornithine carbamoyltransferase inhibitor | 0.046 0.044 CID_54460935 | ||
| 0.104 | 0.037 | 0.207 | Catalase inhibitor | 0.207 0.014 CID_54460935 | CID_54460935 | |
| 0.156 | 0.092 | 0.156 | ATPase inhibitor | |||
| 0.098 | 0.034 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 CID_54460935 | CID_54460935 | |
| 0.079 | 0.016 | 0.079 | Glucosylceramidase inhibitor | |||
| 0.116 | 0.053 | 0.116 | AMP-activated protein kinase stimulant | |||
| 0.07 | 0.007 | 0.07 | Cytokine production stimulant | |||
| 0.161 | 0.099 | 0.161 | Hepatoprotectant | |||
| 0.084 | 0.023 | 0.084 | NMDA 2C receptor antagonist | 0.078 0.027 CID_54460935 | ||
| 0.07 | 0.009 | 0.089 | Phosphoglycerate kinase inhibitor | 0.089 0.008 CID_54460935 | CID_54460935 | |
| 0.075 | 0.016 | 0.075 | Prolactin release inhibitor | |||
| 0.067 | 0.009 | 0.067 | Dihydropteroate synthase inhibitor | 0.044 0.022 CID_54460935 | ||
| 0.104 | 0.046 | 0.122 | Phosphodiesterase 6D inhibitor | 0.122 0.023 CID_54460935 | CID_54460935 | |
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | |||
| 0.112 | 0.055 | 0.112 | Ephrin antagonist | |||
| 0.145 | 0.088 | 0.145 | Melanin inhibitor | |||
| 0.101 | 0.045 | 0.101 | Histamine N-methyltransferase inhibitor | |||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | |||
| 0.177 | 0.121 | 0.177 | ErbB-1 antagonist | |||
| 0.079 | 0.023 | 0.079 | I kappa B kinase 2 inhibitor | |||
| 0.134 | 0.081 | 0.134 | Lipid peroxidase inhibitor | |||
| 0.102 | 0.05 | 0.102 | Alcohol dehydrogenase inhibitor | |||
| 0.112 | 0.06 | 0.112 | Topoisomerase I inhibitor | |||
| 0.069 | 0.018 | 0.069 | Dihydroorotate oxidase inhibitor | |||
| 0.075 | 0.024 | 0.075 | Phosphodiesterase 1C inhibitor | |||
| 0.243 | 0.192 | 0.243 | Alpha-glucosidase inhibitor | |||
| 0.157 | 0.107 | 0.157 | Non-steroidal antiinflammatory agent | |||
| 0.103 | 0.053 | 0.103 | Potassium channel (Ca-activated) activator | |||
| 0.163 | 0.114 | 0.163 | Growth factor agonist | |||
| 0.06 | 0.011 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 CID_54460935 | CID_54460935 | |
| 0.059 | 0.011 | 0.071 | Dihydrofolate reductase inhibitor | 0.071 0.006 CID_54460935 | CID_54460935 | |
| 0.059 | 0.01 | 0.059 | Fumarate hydratase inhibitor | |||
| 0.075 | 0.027 | 0.075 | Androgen agonist | |||
| 0.061 | 0.014 | 0.061 | AICAR transformylase inhibitor | 0.046 0.027 CID_54460935 | ||
| 0.111 | 0.064 | 0.111 | 5 Hydroxytryptamine 3A agonist | |||
| 0.102 | 0.055 | 0.102 | Glutamate (mGluR7) agonist | |||
| 0.099 | 0.052 | 0.118 | Bile acid receptor antagonist | 0.118 0.021 CID_54460935 | CID_54460935 | |
| 0.064 | 0.017 | 0.064 | Immunoglobulin Fc receptor antagonist | |||
| 0.075 | 0.028 | 0.075 | Xanthine dehydrogenase inhibitor | |||
| 0.084 | 0.041 | 0.087 | Cathepsin G inhibitor | 0.087 0.039 CID_54460935 | CID_54460935 | |
| 0.065 | 0.022 | 0.065 | Epithelial sodium channel blocker | |||
| 0.068 | 0.025 | 0.068 | NMDA 2A receptor antagonist | |||
| 0.115 | 0.072 | 0.115 | DNA polymerase I inhibitor | |||
| 0.064 | 0.022 | 0.064 | H+/K+-transporting ATPase inhibitor | 0.052 0.034 CID_54460935 | ||
| 0.057 | 0.015 | 0.057 | Geranyltranstransferase inhibitor | |||
| 0.057 | 0.015 | 0.057 | Thymidine kinase inhibitor | |||
| 0.052 | 0.011 | 0.052 | Glutamate (mGluR3) antagonist | |||
| 0.049 | 0.008 | 0.049 | Uridine phosphorylase inhibitor | |||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | |||
| 0.08 | 0.041 | 0.08 | Vanilloid 4 agonist | |||
| 0.052 | 0.014 | 0.052 | Sphingosine kinase 1 inhibitor | |||
| 0.07 | 0.032 | 0.073 | Carbonic anhydrase IX inhibitor | 0.073 0.03 CID_54460935 | CID_54460935 | |
| 0.088 | 0.05 | 0.088 | Inducible nitric-oxide synthase inhibitor | 0.087 0.052 CID_54460935 | ||
| 0.051 | 0.013 | 0.051 | Estrogen-related receptor alpha antagonist | |||
| 0.085 | 0.049 | 0.085 | Thioredoxin reductase inhibitor | |||
| 0.056 | 0.02 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.061 | 0.025 | 0.061 | Antimetabolite | |||
| 0.052 | 0.016 | 0.052 | Dopamine D5 agonist | |||
| 0.076 | 0.04 | 0.076 | Leukotriene synthesis inhibitor | |||
| 0.057 | 0.022 | 0.057 | Factor III inhibitor | |||
| 0.045 | 0.01 | 0.045 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.131 | 0.096 | 0.131 | Heat shock protein 90 antagonist | |||
| 0.079 | 0.045 | 0.079 | Adenosine A3 receptor antagonist | |||
| 0.151 | 0.117 | 0.151 | Interleukin antagonist | |||
| 0.068 | 0.034 | 0.068 | Adenosine A1 receptor antagonist | |||
| 0.059 | 0.025 | 0.059 | Beta 2 adrenoreceptor antagonist | |||
| 0.058 | 0.025 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.126 | 0.094 | 0.126 | Cytidine deaminase inhibitor | |||
| 0.053 | 0.022 | 0.053 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.066 | 0.034 | 0.066 | Cyclin D1 inhibitor | |||
| 0.041 | 0.009 | 0.041 | Glutamate (mGluR3) agonist | |||
| 0.101 | 0.07 | 0.101 | Falcipain 3 inhibitor | |||
| 0.081 | 0.05 | 0.081 | Somatostatin 1 agonist | |||
| 0.037 | 0.006 | 0.037 | Estrogen-related receptor gamma antagonist | |||
| 0.06 | 0.029 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.172 | 0.142 | 0.172 | Peptidyltransferase inhibitor | |||
| 0.064 | 0.034 | 0.064 | EphB4 antagonist | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | |||
| 0.157 | 0.127 | 0.157 | MAP kinase kinase 5 inhibitor | |||
| 0.162 | 0.132 | 0.162 | Free radical scavenger | |||
| 0.064 | 0.034 | 0.064 | Ribonucleotide reductase inhibitor | |||
| 0.064 | 0.035 | 0.064 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.066 | 0.038 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 CID_54460935 | ||
| 0.111 | 0.084 | 0.111 | Nav1.3 sodium channel blocker | |||
| 0.068 | 0.041 | 0.068 | Beta adrenoreceptor antagonist | |||
| 0.061 | 0.034 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.133 | 0.106 | 0.133 | Heat shock protein 90 alpha antagonist | |||
| 0.055 | 0.028 | 0.055 | AMPA receptor antagonist | |||
| 0.126 | 0.1 | 0.126 | Acetylcholine M1 receptor antagonist | |||
| 0.144 | 0.118 | 0.144 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.065 | 0.04 | 0.065 | Adenosine A2a receptor antagonist | |||
| 0.093 | 0.068 | 0.093 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.066 | 0.041 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.044 | 0.02 | 0.044 | AMPA 4 receptor antagonist | |||
| 0.043 | 0.02 | 0.043 | Diamine oxidase inhibitor | |||
| 0.072 | 0.049 | 0.107 | Phospholipase D inhibitor | 0.107 0.011 CID_54460935 | CID_54460935 | |
| 0.053 | 0.029 | 0.053 | CD45 antagonist | |||
| 0.084 | 0.06 | 0.154 | NMDA receptor antagonist | 0.154 0.023 CID_54460935 | CID_54460935 | |
| 0.034 | 0.01 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.084 | 0.061 | 0.084 | Vanilloid agonist | |||
| 0.064 | 0.042 | 0.064 | Calcium channel P-type blocker | |||
| 0.087 | 0.064 | 0.087 | Phosphodiesterase I inhibitor | |||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.07 | 0.048 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.187 | 0.166 | 0.187 | 12-Lipoxygenase inhibitor | |||
| 0.042 | 0.02 | 0.042 | Arginase inhibitor | |||
| 0.058 | 0.037 | 0.058 | Bruton tyrosine kinase inhibitor | |||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR4) antagonist | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.111 | 0.09 | 0.111 | Tubulin antagonist | |||
| 0.044 | 0.023 | 0.044 | NMDA receptor subunit 3A antagonist | |||
| 0.03 | 0.009 | 0.03 | Complement factor 1s inhibitor | |||
| 0.071 | 0.05 | 0.139 | NMDA 2 receptor antagonist | 0.139 0.019 CID_54460935 | CID_54460935 | |
| 0.089 | 0.068 | 0.089 | ABCA1 expression enhancer | |||
| 0.061 | 0.041 | 0.061 | Aromatase inhibitor | |||
| 0.113 | 0.092 | 0.113 | NADPH oxidase inhibitor | |||
| 0.09 | 0.07 | 0.09 | Xanthine oxidase inhibitor | |||
| 0.045 | 0.025 | 0.045 | Kainate receptor antagonist | |||
| 0.054 | 0.035 | 0.092 | Heparanase inhibitor | 0.092 0.004 CID_54460935 | CID_54460935 | |
| 0.059 | 0.04 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.062 | 0.043 | 0.062 | Histone deacetylase SIRT3 inhibitor | |||
| 0.033 | 0.013 | 0.033 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.021 CID_54460935 | ||
| 0.057 | 0.038 | 0.057 | Leukotriene C antagonist | |||
| 0.134 | 0.116 | 0.134 | Interleukin 6 antagonist | |||
| 0.045 | 0.027 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.022 | 0.039 | Integrin alpha2 antagonist | |||
| 0.029 | 0.012 | 0.029 | Sodium/glucose cotransporter inhibitor | |||
| 0.039 | 0.022 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.033 | 0.017 | 0.033 | Liver X receptor beta antagonist | |||
| 0.074 | 0.058 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.028 | 0.012 | 0.06 | Glutamate (mGluR1) agonist | 0.06 0.004 CID_54460935 | CID_54460935 | |
| 0.044 | 0.028 | 0.044 | Glutamate (mGluR group III) agonist | |||
| 0.026 | 0.011 | 0.026 | Beta 1 adrenoreceptor agonist | |||
| 0.181 | 0.166 | 0.181 | Transcription factor STAT inhibitor | |||
| 0.023 | 0.008 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.104 | 0.089 | 0.104 | Interleukin 8 antagonist | |||
| 0.029 | 0.014 | 0.029 | Integrin alpha2beta1 antagonist | |||
| 0.051 | 0.037 | 0.051 | Glucose-6-phosphate translocase inhibitor | |||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.043 | 0.028 | 0.043 | Angiotensin AT1 receptor antagonist | |||
| 0.091 | 0.077 | 0.091 | Urease inhibitor | |||
| 0.033 | 0.019 | 0.033 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.022 | 0.008 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | |||
| 0.043 | 0.03 | 0.043 | GABA B receptor antagonist | |||
| 0.096 | 0.083 | 0.123 | Nav1.4 sodium channel blocker | 0.123 0.049 CID_54460935 | CID_54460935 | |
| 0.079 | 0.066 | 0.079 | Androgen antagonist | |||
| 0.137 | 0.125 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.025 | 0.013 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | |||
| 0.021 | 0.009 | 0.021 | Antibiotic Anthracycline-like | |||
| 0.061 | 0.05 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.053 CID_54460935 | ||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.019 | 0.008 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | |||
| 0.028 | 0.017 | 0.028 | Lysine carboxypeptidase inhibitor | |||
| 0.019 | 0.008 | 0.019 | Adenosine A2a receptor agonist | |||
| 0.06 | 0.049 | 0.06 | 5 Hydroxytryptamine 3 agonist | |||
| 0.129 | 0.118 | 0.129 | MAP kinase kinase 4 inhibitor | |||
| 0.058 | 0.048 | 0.134 | Carbonic anhydrase inhibitor | 0.134 0.019 CID_54460935 | CID_54460935 | |
| 0.019 | 0.009 | 0.019 | Adenosine A2 receptor agonist | |||
| 0.039 | 0.028 | 0.039 | Membrane dipeptidase inhibitor | |||
| 0.085 | 0.075 | 0.085 | MAO A inhibitor | |||
| 0.038 | 0.028 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.023 | 0.014 | 0.023 | Adenosine kinase inhibitor | |||
| 0.137 | 0.128 | 0.137 | Pyruvate kinase inhibitor | |||
| 0.038 | 0.029 | 0.038 | Urate transporter 1 inhibitor | |||
| 0.114 | 0.105 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.018 | 0.01 | 0.018 | Telomerase stimulant | |||
| 0.017 | 0.009 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.008 CID_54460935 | CID_54460935 | |
| 0.048 | 0.04 | 0.048 | Carbonic anhydrase XII inhibitor | |||
| 0.023 | 0.014 | 0.126 | Glutamate (mGluR1a) agonist | 0.126 0.003 CID_54460935 | CID_54460935 | |
| 0.074 | 0.066 | 0.107 | Glycine receptor antagonist | 0.107 0.026 CID_54460935 | CID_54460935 | |
| 0.035 | 0.027 | 0.035 | Antibiotic Aminoglycoside-like | |||
| 0.025 | 0.017 | 0.025 | Vanilloid 2 agonist | |||
| 0.035 | 0.027 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.047 | 0.04 | 0.047 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.053 | 0.046 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 CID_54460935 | CID_54460935 | |
| 0.033 | 0.026 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.018 | 0.011 | 0.018 | Ileal bile acid transport inhibitor | |||
| 0.051 | 0.045 | 0.051 | Beta 1 adrenoreceptor antagonist | |||
| 0.086 | 0.081 | 0.086 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.049 | 0.044 | 0.049 | Maillard reaction inhibitor | |||
| 0.121 | 0.116 | 0.147 | Phospholipase A2 inhibitor | 0.147 0.077 CID_54460935 | CID_54460935 | |
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.17 | 0.166 | 0.17 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.042 | 0.038 | 0.042 | Carbonic anhydrase VII inhibitor | |||
| 0.111 | 0.107 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.022 | 0.018 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.012 | 0.008 | 0.012 | Purine nucleoside phosphorylase inhibitor | |||
| 0.048 | 0.044 | 0.048 | Toll-Like receptor 8 antagonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.027 | 0.024 | 0.027 | Liver X receptor alpha antagonist | |||
| 0.031 | 0.028 | 0.031 | Retinoid X alpha receptor agonist | |||
| 0.032 | 0.029 | 0.032 | Angiotensin II receptor antagonist | |||
| 0.02 | 0.017 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.234 | 0.231 | 0.234 | Cyclophilin D inhibitor | |||
| 0.026 | 0.024 | 0.026 | AMPA 3 receptor antagonist | |||
| 0.037 | 0.035 | 0.037 | Leukotriene C4 antagonist | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.078 | 0.077 | 0.078 | MAO B inhibitor | |||
| 0.028 | 0.035 | 0.068 | Purinergic P2Y2 antagonist | 0.068 0.006 CID_54460935 | CID_54460935 | |
| 0.019 | 0.026 | 0.028 | Purinergic P2X agonist | 0.028 0.019 CID_54460935 | CID_54460935 | |
| 0.027 | 0.04 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.024 CID_54460935 | CID_54460935 | |
| 0.04 | 0.053 | 0.069 | Carbonic anhydrase I inhibitor | 0.069 0.029 CID_54460935 | CID_54460935 | |
| 0.039 | 0.055 | 0.054 | Carbonic anhydrase II inhibitor | 0.054 0.04 CID_54460935 | CID_54460935 | |
| 0.198 | 0.216 | 0.328 | 15-Lipoxygenase inhibitor | 0.328 0.112 CID_54460935 | CID_54460935 | |
| 0.098 | 0.12 | 0.15 | Alkaline phosphatase inhibitor | 0.15 0.06 CID_54460935 | CID_54460935 | |
| 0.021 | 0.05 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_54460935 | CID_54460935 | |
| 0.062 | 0.093 | 0.076 | Chymotrypsin inhibitor | 0.076 0.059 CID_54460935 | CID_54460935 | |
| 0.101 | 0.134 | 0.183 | Diuretic | 0.183 0.052 CID_54460935 | CID_54460935 | |
| 0.019 | 0.06 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_54460935 | CID_54460935 | |
| 0.035 | 0.08 | 0.235 | Factor IXa inhibitor | 0.235 0.003 CID_54460935 | CID_54460935 | |
| 0.037 | 0.083 | 0.334 | Selectin antagonist | 0.334 0.004 CID_54460935 | CID_54460935 | |
| 0.097 | 0.149 | 0.328 | Protein-tyrosine phosphatase inhibitor | 0.328 0.015 CID_54460935 | CID_54460935 | |
| 0.026 | 0.08 | 0.061 | Leukocyte elastase inhibitor | 0.061 0.018 CID_54460935 | CID_54460935 | |
| 0.101 | 0.16 | 0.608 | Dual specificity phosphatase 3 inhibitor | 0.608 0.004 CID_54460935 | CID_54460935 | |
| 0.05 | 0.112 | 0.286 | CDC25A inhibitor | 0.286 0.004 CID_54460935 | CID_54460935 | |
| 0.036 | 0.131 | 0.129 | Neuraminidase (influenza) inhibitor | 0.129 0.01 CID_54460935 | CID_54460935 | |
| 0.014 | 0.109 | 0.111 | Factor Xa inhibitor | 0.111 0.012 CID_54460935 | CID_54460935 | |
| 0.081 | 0.177 | 0.127 | Antibacterial (Helicobacter pylori) | 0.127 0.072 CID_54460935 | CID_54460935 | |
| 0.091 | 0.207 | 0.595 | Dual specificity phosphatase inhibitor | 0.595 0.005 CID_54460935 | CID_54460935 | |
| 0.022 | 0.141 | 0.081 | Neuraminidase inhibitor | 0.081 0.025 CID_54460935 | CID_54460935 | |
| 0.029 | 0.148 | 0.087 | HIV-1 integrase (3'-Processing) inhibitor | 0.087 0.031 CID_54460935 | CID_54460935 | |
| 0.069 | 0.201 | 0.161 | Cell adhesion inhibitor | 0.161 0.04 CID_54460935 | CID_54460935 | |
| 0.021 | 0.156 | 0.085 | HIV-1 integrase (Strand Transfer) inhibitor | 0.085 0.029 CID_54460935 | CID_54460935 | |
| 0.039 | 0.185 | 0.124 | Protein-tyrosine phosphatase 1B inhibitor | 0.124 0.06 CID_54460935 | CID_54460935 | |
| 0.118 | 0.293 | 0.893 | Angiogenesis inhibitor | 0.893 0.005 CID_54460935 | CID_54460935 | |
| 0.021 | 0.198 | 0.257 | NMDA 2B receptor antagonist | 0.257 0.005 CID_54460935 | CID_54460935 | |
| 0.009 | 0.19 | 0.063 | NMDA 2D receptor antagonist | 0.063 0.005 CID_54460935 | CID_54460935 | |
| 0.047 | 0.247 | 0.285 | Thrombolytic | 0.285 0.026 CID_54460935 | CID_54460935 | |
| 0.026 | 0.235 | 0.114 | Thrombin inhibitor | 0.114 0.02 CID_54460935 | CID_54460935 | |
| 0.025 | 0.244 | 0.113 | Fibroblast growth factor 1 antagonist | 0.113 0.048 CID_54460935 | CID_54460935 | |
| 0.014 | 0.249 | 0.484 | Cholecystokinin B agonist | 0.484 0.002 CID_54460935 | CID_54460935 | |
| 0.059 | 0.334 | 0.189 | Platelet adhesion inhibitor | 0.189 0.077 CID_54460935 | CID_54460935 | |
| 0.004 | 0.303 | 0.137 | Cholecystokinin A antagonist | 0.137 0.005 CID_54460935 | CID_54460935 | |
| 0.004 | 0.326 | 0.064 | Cholecystokinin B antagonist | 0.064 0.008 CID_54460935 | CID_54460935 | |
| 0.038 | 0.363 | 0.723 | Anticoagulant | 0.723 0.005 CID_54460935 | CID_54460935 | |
| 0.004 | 0.343 | 0.083 | Cholecystokinin antagonist | 0.083 0.011 CID_54460935 | CID_54460935 | |
| 0.026 | 0.37 | 0.158 | Cell adhesion molecule inhibitor | 0.158 0.014 CID_54460935 | CID_54460935 | |
| 0.01 | 0.413 | 0.094 | Elastase inhibitor | 0.094 0.011 CID_54460935 | CID_54460935 | |
| 0.003 | 0.602 | 0.26 | Cholecystokinin agonist | 0.26 0.003 CID_54460935 | CID_54460935 | |
| 0.003 | 0.61 | 0.212 | Cholecystokinin A agonist | 0.212 0.003 CID_54460935 | CID_54460935 | |
| 0.013 | 0.664 | 0.117 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.051 CID_54460935 | CID_54460935 | |
| 0.002 | 0.667 | 0.029 | Estrone sulfatase inhibitor | 0.029 0.011 CID_54460935 | CID_54460935 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |